Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Plexin A1 ELISA Kit (AC2679)
Cat.#: ASET-1268
Specifications
Description Human Plexin A1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Plexin A1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.14 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2098 Human LCN1 ELISA Kit (AC3509) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-1237 Human NRXN3 ELISA Kit (AC2648) Quantitative inquiry ASET-2339 Human Cathepsin B ELISA Kit (AC3750) Quantitative inquiry ASET-1057 Human COMT ELISA Kit (AC2468) Quantitative inquiry ASET-1289 Human Semaphorin 3E ELISA Kit (AC2700) Quantitative inquiry ASET-1620 Human SOX2 ELISA Kit (AC3031) Quantitative inquiry ASET-1852 Mouse Thrombospondin 1 ELISA Kit (AC3263) Quantitative inquiry ASET-2516 Mouse alpha B Crystallin ELISA Kit (AC3927) Quantitative inquiry ASET-1434 Rat Rabphilin 3A ELISA Kit (AC2845) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket